MAPK1 and chronic obstructive pulmonary disease: A selective p38 inhibitor (GW856553) was reported to potentiate the repression of pro-inflammatory cytokines by GCs in PBMCs from COPD patients due to the decreased phosphorylation of GR-S211, mediated by p38 [87].